Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder
Open accessPublished version of a preprint
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 13 of the 68 sources its claims cite were checked for support.
Abstract
Patients with obsessive-compulsive disorder (OCD) have been found to show exaggerated error responses and prediction error learning signals in a variety of EEG and fMRI tasks, with data converging on the anterior cingulate cortex as a key locus of dysfunction. Considerable evidence has linked prediction error processing to dopaminergic function. In this study, we investigate potential dopaminergic dysfunction during reward processing in the context of OCD. We studied OCD patients ( n = 18) and controls ( n = 18) whilst they learned probabilistic associations between abstract stimuli and monetary rewards in the fMRI scanner involving administration (on separate visits) of a dopamine receptor agonist, pramipexole 0.5 mg; a dopamine receptor antagonist, amisulpride 400 mg; and placebo. We fitted a Q-learning computational model to fMRI prediction error responses; group differences were examined in anterior cingulate and nucleus accumbens regions of interest. There were no significant group, drug, or interaction effects in the number of correct choices; computational modeling suggested a marginally significant difference in learning rates between groups ( p = 0.089, partial ƞ 2 = 0.1). In the imaging results, there was a significant interaction of group by drug ( p = 0.013, partial ƞ 2 = 0.13). OCD patients showed abnormally strong cingulate signaling of prediction errors during omission of an expected reward, with unexpected reduction by both pramipexole and amisulpride ( p = 0.014, partial ƞ 2 = 0.26, 1-β error probability = 0.94). Exaggerated cingulate prediction error signaling to omitted reward in placebo was related to trait subjective difficulty in self-regulating behavior in OCD. Our data support cingulate dysfunction during reward processing in OCD, and bidirectional remediation by dopaminergic modulation, suggesting that exaggerated cingulate error signals in OCD may be of dopaminergic origin. The results help to illuminate the mechanisms through which dopamine receptor antagonists achieve therapeutic benefit in OCD. Further research is needed to disentangle the different functions of dopamine receptor agonists and antagonists during bidirectional modulation of cingulate activation.
Overview
CoChat Summary
TL;DR
In this double-blind, placebo-controlled fMRI study, OCD patients showed exaggerated anterior cingulate negative reward prediction error signaling under placebo, which was reduced by acute pramipexole or amisulpride. The findings support cingulate dopaminergic dysfunction in OCD, though behavioral learning effects were limited and the bidirectional drug effect was unexpected.
Key findings
- Under placebo, OCD patients had abnormally strong anterior cingulate signaling of negative prediction errors during omitted reward compared with controls (OCD mean = 128.57, SD = 189.54 vs controls mean = −42.21, SD = 140.24; F = 8.84, p = 0.006, partial ƞ² = 0.22). Both pramipexole and amisulpride reduced this signal in OCD patients (drug effect F = 5.01, p = 0.014, partial ƞ² = 0.26; placebo > amisulpride p = 0.030; placebo > pramipexole p = 0.017; amisulpride vs pramipexole p = 0.70), with a significant group-by-drug interaction (p = 0.013, partial ƞ² = 0.13).
- In the nucleus accumbens, OCD patients showed increased positive prediction error responses under placebo (OCD mean = 125.74, SD = 113.32 vs controls mean = 32.28, SD = 120.46; F = 5.11, p = 0.031, partial ƞ² = 0.15), with a significant main effect of group (F = 11.82, p = 0.002, partial ƞ² = 0.28) but no drug effect (p = 0.45) or group-by-drug interaction (p = 0.54).
- Behavioral choice performance showed no significant drug effect (p = 0.39) or group-by-drug interaction (p = 0.86), and only a marginal group difference in correct choices (p = 0.070, partial ƞ² = 0.09); computational modeling showed a marginal group difference in learning rate (p = 0.089, partial ƞ² = 0.1; controls mean α = 0.27, SE = 0.02 vs OCD mean α = 0.22, SE = 0.02).
- Placebo cingulate negative prediction error signal correlated with trait self-regulation in OCD patients (rho = −0.7, p = 0.002; rho = −0.75, p = 0.002 excluding outliers) but not with Y-BOCS symptoms (rho = −0.2, p = 0.4).
Methods
- Double-blind, placebo-controlled, within-subject pharmacological fMRI study of 18 OCD patients and 18 healthy controls, matched for age, gender, IQ, and years of education; participants attended three visits receiving pramipexole 0.5 mg, amisulpride 400 mg, or placebo 60 min before scanning.
- During fMRI, participants performed a probabilistic learning task with rewarding, punishing, and neutral stimulus pairs (40 trials each); the reported imaging analyses focused on reward trials, and a Q-learning computational model estimated positive and negative reward prediction errors.
- Region-of-interest analyses used the anterior cingulate cortex (14 mm sphere at x = 0, y = 42, z = 18) and nucleus accumbens (Harvard-Oxford subcortical atlas), with repeated measures ANOVA and Spearman correlations with behavioral scales.
Limitations
- Stated: a full dose-response curve was not feasible; the 0.5 mg pramipexole dose may have produced primarily presynaptic effects, and the initially intended 1.5 mg dose was poorly tolerated.
- Stated: 16 of 18 OCD patients were taking medication for OCD at study time, though the dopaminergic treatment effect was present irrespective of SSRI dose; sample sizes were modest and the study may have been underpowered for some comparisons, with retrospective power 1-β > 0.7.
- Stated/evident: controls showed no clear cingulate negative prediction error signal, possibly because only 40 reward-pair trials were used; punishment prediction error signals were not analyzed or hypothesized, and the study used acute single-dose drug administration rather than chronic clinical treatment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
9 Valid · 1 Not valid · 24 Not checked · 60 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Considerable evidence has linked prediction error processing to dopaminergic function.”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Abstract > Rationale
What the sources say
- Supportedcites Schultz et al. 1997 matched to “A neural substrate of prediction and reward” (1997) source
The Summary and Future Questions (p. 5) states the paper reviews evidence supporting the proposal that dopamine neurons in the VTA and substantia nigra report ongoing prediction errors for reward. Information Encoded in Dopaminergic Activity (p. 2) likewise describes dopamine neurons coding a deviation/error between actual reward and predictions, with positive, null and negative signals. This directly backs the broad attribution that considerable evidence links prediction error processing to dopaminergic function. (LLM, conf=0.92)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, dopamine-dependent activation in the anterior cingulate has also been associated with increased error awareness and performance monitoring (Hester et al. 2012; Pauls et al. 2012).”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Introduction
What the sources say
- Supportedcites Hester et al. 2012 matched to “Neurochemical Enhancement of Conscious Error Awareness” (2012) source
The Discussion passage (section 'Discussion', para. beginning 'awareness in nonclinical adults...') states that MPH, an indirect DA agonist, promoted conscious error awareness and that this behavioural improvement was underpinned by significantly larger dACC activity differences between aware and unaware trials versus placebo, and links this to Holroyd and Coles' dopamine-based performance-monitoring account. The Abstract and Discussion conclusion likewise report the dopaminergic (catecholaminergic) modulation of dorsal ACC activation associated with error awareness, while Figure 3 reports dACC activity differentiating aware from unaware errors. The claim's hedged phrasing ('associated with') matches the paper's 'broadly consistent with this hypothesis', so the paraphrase is supported. (LLM, conf=0.85)
- Partly supportedcites Pauls et al. 2012 matched to “Methylphenidate Effects on Prefrontal Functioning During Attentional-Capture and Response Inhibition” (2012) sourceExperimental — accuracy not yet measured
The Results section ('Methylphenidate Effects on Failed Stop Versus Attentional-Capture Trials') does report methylphenidate relative to placebo increasing BOLD signal in dorsomedial frontal cortex 'including pre-SMA and anterior cingulate, a typical region involved in error processing and performance monitoring', and the Discussion confirms 'Methylphenidate increased activation within the medial frontal and the anterior cingulate, on error trials'. However, the error-awareness component is explicitly hedged in the source: the authors write 'we speculate that methylphenidate enhances attention allocation to trial errors ... presumably leading to a more conscious processing of errors', resting the dopamine link on 'the notion that phasic dopamine response modulates error-related mesial frontal activation', and noting the effect was only detected when controlling for attentional capture. The citing sentence states as an established association what this paper offers as speculation, and the dopamine-specific framing is the paper's inference from a catecholamine-reuptake blocker rather than a direct dopamine measurement. (LLM, conf=0.72)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Reward prediction error processing is closely linked to the dopaminergic system (Schultz et al. 1997).”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Introduction
What the sources say
- Supportedcites Schultz et al. 1997 matched to “A neural substrate of prediction and reward” (1997) source
The paper's central thesis is exactly this link: 'Information Encoded in Dopaminergic Activity' (p. 2) states that dopamine neuron outputs 'code for a deviation or error between the actual reward received and predictions of the time and magnitude of reward,' with positive/null/negative signals depending on prediction. The Summary (p. 5) reiterates that 'dopamine neurons in the VTA and the substantia nigra report ongoing prediction errors for reward,' and the model sections (pp. 3-4) formalize the prediction error as the output of dopaminergic firing. The citing sentence is a broad background paraphrase fully borne out by our copy. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Exaggerated cingulate prediction error signaling to omitted reward in placebo was related to trait subjective difficulty in self-regulating behavior in OCD.”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the imaging results, there was a significant interaction of group by drug (p = 0.013, partial ƞ2 = 0.13).”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 94 claims and to verify the 55 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 29
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the normalization effects of stimulants aligning with the underactivity of MCC echoes previous evidence that stimulants may improve cingulate dysfunction through bidirectional remediation by dopaminergic modulation, and the DA system controlled by cholinergic receptors in the MCC is a likely target”
From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Murray et al., 2019
Experimental — accuracy not yet measuredIn the citing paper
“may be an effective augmentative strategy for some OCD treatment resistant patients [155].”
From Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder (2021) · cites this paper as [155]
In the citing paper
“The anterior cingulate cortex (ACC), which participates in emotional processing functions of the fronto-limbic circuit [36], is also critically involved in processing reward signals relayed from the NAcc [135] and has been found to be hyperactive during reward tasks in OCD [155].”
From Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder (2021) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Results > Imaging results: nucleus accumbens, positive prediction error
“controls (mean = 89.15, SD = 125.77) > OCD”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Results > Imaging results: nucleus accumbens, positive prediction error
“OCD (mean = 110.81, SD = 122.66)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Results > Imaging results: anterior cingulate cortex, negative prediction error
“amisulpride > pramipexole, p = 0.70.”
§ Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder > Results > Imaging results: anterior cingulate cortex, negative prediction error
“amisulpride (mean = − 40.03, SD = 157.35) as well as pramipexole (mean = − 20.83, SD = 133.09)”
Citations
Cites
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.015 · Cited by 11,314
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Statistical Methods for Psychology.
Gudgeon, A. C., & Howell, D. C. (1994) · The Statistician · doi:10.2307/2348956 · Cited by 8,278 · cited 1×
“Before ANOVA was performed, we examined the distributions of the COPE values and excluded outliers more than three standard deviations away from the mean of all the samples pooled (Howell 2009).”
MethodThe Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Dissociable Roles of Ventral and Dorsal Striatum in Instrumental Conditioning
O'Doherty, J., Dayan, P., Schultz, J., Deichmann, R., Friston, K., & Dolan, R. J. (2004) · Science · doi:10.1126/science.1094285 · Cited by 2,088
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
By Carrot or by Stick: Cognitive Reinforcement Learning in Parkinsonism
Frank, M. J., Seeberger, L. C., & O'Reilly, R. C. (2004) · Science · doi:10.1126/science.1102941 · Cited by 1,964
Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans
Pessiglione, M., Seymour, B., Flandin, G., Dolan, R. J., & Frith, C. D. (2006) · Nature · doi:10.1038/nature05051 · Cited by 1,584
Neuronal Coding of Prediction Errors
Schultz, W., & Dickinson, A. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.473 · Cited by 1,427
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 934
Denys, D., Mantione, M., Figee, M., van den Munckhof, P., Koerselman, F., Westenberg, H., Bosch, A., & Schuurman, R. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.122 · Cited by 763
The role of D2-autoreceptors in regulating dopamine neuron activity and transmission
Ford, C. P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.025 · Cited by 590
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis
Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532 · cited 2×
“The lack of clear prediction errors in controls may have resulted from our procedure containing only 40 reward pair stimuli trials; for comparison, other prior prediction error fMRI studies have included larger numbers of potentially rewarding trials, such as 80 (Murray et al. 2008) or 90 (Pessiglione et al.”
MethodResultObsessive-Compulsive Disorder: Advances in Diagnosis and Treatment
Hirschtritt, M. E., Bloch, M. H., & Mathews, C. A. (2017) · JAMA · doi:10.1001/jama.2017.2200 · Cited by 493
The self-regulation questionnaire.
Brown, J. M., Miller, W. R., & Lawendowski, L. A. (1999) · Cited by 491
Activity in human ventral striatum locked to errors of reward prediction
Pagnoni, G., Zink, C. F., Montague, P. R., & Berns, G. S. (2002) · Nature Neuroscience · doi:10.1038/nn802 · Cited by 451
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398
Self-citationPrediction error as a linear function of reward probability is coded in human nucleus accumbens
Abler, B., Walter, H., Erk, S., Kammerer, H., & Spitzer, M. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.001 · Cited by 376
Goal-directed learning and obsessive-compulsive disorder
Gillan, C. M., & Robbins, T. W. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0475 · Cited by 348
Self-citationUrsu, S., Stenger, V. A., Shear, M. K., Jones, M. R., & Carter, C. S. (2003) · Psychological Science · doi:10.1111/1467-9280.24411 · Cited by 341
Dysfunctional reward circuitry in obsessive-compulsive disorder
Figee, M., Vink, M., de Geus, F., Vulink, N., Veltman, D. J., Westenberg, H., & Denys, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.003 · Cited by 315
Jocham, G., Klein, T. A., & Ullsperger, M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3904-10.2011 · Cited by 278
Perrault, G., Depoortere, R., Morel, E., Sanger, D. J., & Scatton, B. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36394-3 · Cited by 229 · cited 1×
“whereas higher doses were found to decrease behaviors associated with postsynaptic receptor activation (Perrault et al. 1997).”
BackgroundPerani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Pizzagalli, D. A., Evins, A. E., Schetter, E. C., Frank, M. J., Pajtas, P. E., Santesso, D. L., & Culhane, M. (2008) · Psychopharmacology · doi:10.1007/s00213-007-0957-y · Cited by 219
Dold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000740 · Cited by 211
Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder
Denys, D., van der Wee, N., Janssen, J., De Geus, F., & Westenberg, H. G. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.023 · Cited by 195
Rosenzweig, P., Canal, M., Patat, A., Bergougnan, L., Zieleniuk, I., & Bianchetti, G. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.320 · Cited by 177
Veale, D., Miles, S., Smallcombe, N., Ghezai, H., Goldacre, B., & Hodsoll, J. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0317-5 · Cited by 162
A trans-diagnostic perspective on obsessive-compulsive disorder
Gillan, C. M., Fineberg, N. A., & Robbins, T. W. (2017) · Psychological Medicine · doi:10.1017/s0033291716002786 · Cited by 158
Self-citationClinical practice guidelines for Obsessive-Compulsive Disorder
Janardhan Reddy, Y., Sundar, A., Narayanaswamy, J., & Math, S. (2017) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.196976 · Cited by 156
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder
Hesse, S., Müller, U., Lincke, T., Barthel, H., Villmann, T., Angermeyer, M. C., Sabri, O., & Stengler-Wenzke, K. (2005) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2005.07.002 · Cited by 155
van der Wee, N. J., Stevens, H., Hardeman, J. A., Mandl, R. C., Denys, D. A., van Megen, H. J., Kahn, R. S., & Westenberg, H. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2201 · Cited by 149
Stern, E. R., Welsh, R. C., Fitzgerald, K. D., Gehring, W. J., Lister, J. J., Himle, J. A., Abelson, J. L., & Taylor, S. F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.048 · Cited by 135
Role of Dopamine D2 Receptors in Human Reinforcement Learning
Eisenegger, C., Naef, M., Linssen, A., Clark, L., Gandamaneni, P. K., Müller, U., & Robbins, T. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.84 · Cited by 134
Self-citationDold, M., Aigner, M., Lanzenberger, R., & Kasper, S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv047 · Cited by 134
Ersche, K. D., Roiser, J. P., Abbott, S., Craig, K. J., Müller, U., Suckling, J., Ooi, C., Shabbir, S. S., Clark, L., Sahakian, B. J., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.033 · Cited by 128
Self-citationVentral–striatal/nucleus–accumbens sensitivity to prediction errors during classification learning
Rodriguez, P. F., Aron, A. R., & Poldrack, R. A. (2006) · Human Brain Mapping · doi:10.1002/hbm.20186 · Cited by 122
Muscatello, M. R. A., Bruno, A., Pandolfo, G., Micò, U., Scimeca, G., Romeo, V. M., Santoro, V., Settineri, S., Spina, E., & Zoccali, R. A. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820e3db6 · Cited by 122
Abler, B., Erk, S., & Walter, H. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0690-y · Cited by 118
Steady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers
Wright, C. E., Sisson, T. L., Ichhpurani, A. K., & Peters, G. R. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04330.x · Cited by 117
Coukell, A. J., Spencer, C. M., & Benfield, P. (1996) · CNS Drugs · doi:10.2165/00023210-199606030-00006 · Cited by 108
Sayyah, M., Sayyah, M., Boostani, H., Ghaffari, S. M., & Hoseini, A. (2012) · Depression and Anxiety · doi:10.1002/da.21996 · Cited by 105
Ermakova, A. O., Knolle, F., Justicia, A., Bullmore, E. T., Jones, P. B., Robbins, T. W., Fletcher, P. C., & Murray, G. K. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0056-2 · Cited by 91 · cited 1×
“1), adapted from previous similar tasks (Bernacer et al. 2013; Ermakova et al. 2018; O’doherty et al. 2004; Pessiglione et al. 2006).”
Self-citationD-Amphetamine in obsessive-compulsive disorder
Insel, T. R., Hamilton, J. A., Guttmacher, L. B., & Murphy, D. L. (1983) · Psychopharmacology · doi:10.1007/bf00436159 · Cited by 90
Dopamine D1 receptor binding in the striatum of patients with obsessive–compulsive disorder
Olver, J. S., O'Keefe, G., Jones, G. R., Burrows, G. D., Tochon-Danguy, H. J., Ackermann, U., Scott, A., & Norman, T. R. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.020 · Cited by 88
Hauser, T. U., Iannaccone, R., Dolan, R. J., Ball, J., Hättenschwiler, J., Drechsler, R., Rufer, M., Brandeis, D., Walitza, S., & Brem, S. (2017) · Psychological Medicine · doi:10.1017/s0033291716003305 · Cited by 86
Koran, L. M., Aboujaoude, E., & Gamel, N. N. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04605 · Cited by 79
Mathews, C. A., Perez, V. B., Delucchi, K. L., & Mathalon, D. H. (2012) · Biological Psychology · doi:10.1016/j.biopsycho.2011.12.018 · Cited by 78
Bernacer, J., Corlett, P. R., Ramachandra, P., McFarlane, B., Turner, D. C., Clark, L., Robbins, T. W., Fletcher, P. C., & Murray, G. K. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070978 · Cited by 77
Self-citationFluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301199 · Cited by 70
Neurochemical Enhancement of Conscious Error Awareness
Hester, R., Nandam, L. S., O'Connell, R. G., Wagner, J., Strudwick, M., Nathan, P. J., Mattingley, J. B., & Bellgrove, M. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4052-11.2012 · Cited by 68
Nielen, M. M., den Boer, J. A., & Smid, H. G. O. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005297 · Cited by 58
Methylphenidate Effects on Prefrontal Functioning During Attentional-Capture and Response Inhibition
Pauls, A. M., O'Daly, O. G., Rubia, K., Riedel, W. J., Williams, S. C. R., & Mehta, M. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.028 · Cited by 57
Update on the use of pramipexole in the treatment of Parkinson’s disease
Constantinescu, R. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2325 · Cited by 52
Sesia, T., Bizup, B., & Grace, A. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200154x · Cited by 49
Acute Psychostimulant Challenge in Primary Obsessive-Compulsive Disorder
JOFFE, R. T., SWINSON, R. P., & LEVITT, A. J. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199108000-00003 · Cited by 46
Murray, G. K., Corlett, P. R., & Fletcher, P. C. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq005 · Cited by 46
Self-citationMorein-Zamir, S., Papmeyer, M., Gillan, C. M., Crockett, M. J., Fineberg, N. A., Sahakian, B. J., & Robbins, T. W. (2013) · Psychological Medicine · doi:10.1017/s0033291712001018 · Cited by 43
Self-citationOlver, J. S., O'Keefe, G., Jones, G. R., Burrows, G. D., Tochon-Danguy, H. J., Ackermann, U., Scott, A. M., & Norman, T. R. (2010) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2010.04.004 · Cited by 42
The Effect of Dopamine Agonists on Adaptive and Aberrant Salience in Parkinson's Disease
Nagy, H., Levy-Gigi, E., Somlai, Z., Takáts, A., Bereczki, D., & Kéri, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.278 · Cited by 42
Horst, N. K., Jupp, B., Roberts, A. C., & Robbins, T. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0272-9 · Cited by 38
Self-citationDistinct cortico-striatal connections with subthalamic nucleus underlie facets of compulsivity
Morris, L. S., Baek, K., & Voon, V. (2016) · Cortex · doi:10.1016/j.cortex.2016.12.018 · Cited by 34
Hammer, A., Kordon, A., Heldmann, M., Zurowski, B., & Münte, T. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006553 · Cited by 29
Ercan, E. S., Ardic, U. A., Ercan, E., Yuce, D., & Durak, S. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0128 · Cited by 29
Kolla, B. P., Mansukhani, M. P., Barraza, R., & Bostwick, J. M. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.3.271 · Cited by 28 · cited 2×
“We hypothesized that fronto-striatal reward prediction error signaling in OCD would be exaggerated under placebo; given the evidence for dopamine receptor antagonism add-on treatment for OCD, we hypothesized that this abnormality would be normalized by amisulpride but not by pramipexole, which has been shown in some c…”
BackgroundResultGenome-wide association in bipolar
Gershon, E. S., Liu, C., & Badner, J. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002117 · Cited by 27
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
Gallant, H., Vo, A., Seergobin, K. N., & MacDonald, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00374 · Cited by 26
Perseveration induces dissociative uncertainty in obsessive–compulsive disorder
Giele, C. L., van den Hout, M. A., Engelhard, I. M., Dek, E. C. P., Toffolo, M. B. J., & Cath, D. C. (2016) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2016.02.001 · Cited by 10
Ermakova, A. O., Knolle, F., Justicia, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/214437 · Cited by 10
Self-citation
Cited by
Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder
Shephard, E., Stern, E. R., van den Heuvel, O. A., Costa, D. L. C., Batistuzzo, M. C., Godoy, P. B. G., Lopes, A. C., Brunoni, A. R., Hoexter, M. Q., Shavitt, R. G., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-01007-8 · Cited by 250
Kanen, J. W., Ersche, K. D., Fineberg, N. A., Robbins, T. W., & Cardinal, R. N. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05325-w · Cited by 101
“Murray et al. (2019), compared the same set of OCD and control participants as in our experiment and found that negative prediction errors were enhanced in OCD and that this was normalised by both amisulpride and pramipexole.”
ResultSelf-citationFrom compulsivity to compulsion: the neural basis of compulsive disorders
Robbins, T. W., Banca, P., & Belin, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00807-z · Cited by 160
Self-citationTreatment-resistant OCD: Pharmacotherapies in adults
van Roessel, P. J., Grassi, G., Aboujaoude, E. N., Menchón, J. M., Van Ameringen, M., & Rodríguez, C. I. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152352 · Cited by 86
Social Cognition and Obsessive-Compulsive Disorder: A Review of Subdomains of Social Functioning
Jansen, M., Overgaauw, S., & de Bruijn, E. R. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00118 · Cited by 79
Metadata
- Authors
- Murray, G. K., Knolle, F., Ersche, K. D., Craig, K. J., Abbott, S., Shabbir, S. S., Fineberg, N. A., Suckling, J., Sahakian, B. J., Bullmore, E. T., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- European Bioinformatics Institute (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Queen Elizabeth II Hospital (GB)
- Corresponding author
- Murray, Graham K.
- Knolle, Franziska
- ORCID
- Venue
- Psychopharmacology
- Published
- 2019-06-14
- Volume
- 236
- Issue
- 8
- Pages
- 2325-2336
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC6695357
- OpenAlex
- W2950829296
- Cited by
- 53
- References
- 71
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 10 · 2022: 2 · 2021: 8 · 2020: 7 · 2019: 5
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion, cc-by)
- University of Hertfordshire Research Archive (University of Hertfordshire) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- University of Cambridge
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- obsessive-compulsive disorder, prediction error, anterior cingulate cortex, nucleus accumbens, dopaminergic dysfunction, pramipexole, amisulpride, dopamine agonists, dopamine antagonists, reward processing, learning rate, computational modeling, self-regulation
- MeSH terms
- Adult, Dopamine, Double-Blind Method, Female, Forecasting, Gyrus Cinguli, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nucleus Accumbens, Obsessive-Compulsive Disorder, Photic Stimulation, Reward, Dopamine Agonists, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.